FTRNX
Price
$184.96
Change
+$0.13 (+0.07%)
Updated
Jun 25 closing price
Net Assets
3.83B
GFACX
Price
$68.49
Change
-$0.03 (-0.04%)
Updated
Jun 25 closing price
Net Assets
313.92B
Interact to see
Advertisement

FTRNX vs GFACX

Header iconFTRNX vs GFACX Comparison
Open Charts FTRNX vs GFACXBanner chart's image
Fidelity Trend
Price$184.96
Change+$0.13 (+0.07%)
VolumeN/A
Net Assets3.83B
American Funds Growth Fund of Amer C
Price$68.49
Change-$0.03 (-0.04%)
VolumeN/A
Net Assets313.92B
FTRNX vs GFACX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FTRNX vs. GFACX commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTRNX is a Buy and GFACX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 314B vs. FTRNX (3.83B). FTRNX pays higher dividends than GFACX: FTRNX (0.59) vs GFACX (0.00). FTRNX was incepted earlier than GFACX: FTRNX (67 years) vs GFACX (24 years). GFACX (1.36) is less costly to investors than FTRNX (0.59). FTRNX is a more actively managed with annual turnover of: 64.00 vs. GFACX (25.00). FTRNX has a lower initial minimum investment than GFACX: FTRNX (0) vs GFACX (250). GFACX annual gain was more profitable for investors over the last year : 6.90 vs. FTRNX (-0.04). FTRNX return over 5 years is better than : 57.91 vs. GFACX (41.63).
FTRNXGFACXFTRNX / GFACX
Total Expense Ratio0.591.3643%
Annual Report Gross Expense Ratio0.591.3643%
Fund Existence67 years24 years-
Gain YTD1.7807.41824%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets3.83B314B1%
Annual Yield % from dividends0.590.00-
Returns for 1 year-0.046.90-1%
Returns for 3 years55.6243.25129%
Returns for 5 years57.9141.63139%
Returns for 10 years110.2359.46185%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LUSOX10.53N/A
N/A
Lazard US Systematic Small Cap Eq Open
WEMIX12.32N/A
N/A
Allspring Emerging Growth Inst
MWEGX38.65N/A
N/A
MFS Global Equity R1
HBLTX14.84N/A
N/A
Hartford Balanced Income R5
TSHIX14.90N/A
N/A
Transamerica Multi-Asset Income I